Literature DB >> 11762946

Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells.

D J Radford1, N T Luu, P Hewins, G B Nash, C O Savage.   

Abstract

OBJECTIVE: Recruitment of neutrophils to sites of inflammation requires coordinated regulation of their capture, activation, and migration on vascular endothelium. This study examines whether exposure of neutrophils to antineutrophil cytoplasmic antibodies (ANCAs) can disrupt this sequence of events.
METHODS: Isolated human neutrophils were perfused in the presence or absence of ANCA-positive IgG over endothelial cells that had been activated with either 2 units/ml or 100 units/ml of tumor necrosis factor alpha (TNFalpha) for 4 hours.
RESULTS: When endothelial cells were activated with 100 units/ml of TNFalpha, neutrophils were captured from flow, a small proportion of adherent cells rolled, and the majority transmigrated through the endothelial cell monolayer. When neutrophils were treated with ANCA IgG immediately before, 5 minutes before, or 15 minutes before perfusion, none rolled on contact with the endothelium, but the majority still transmigrated. When endothelial cells were activated with 2 units/ml of TNFalpha, the majority of untreated adherent neutrophils rolled, a few transmigrated, and the number that attached decreased with time during washout. In contrast, when neutrophils were pretreated with ANCA IgG just before perfusion, adhesion was stabilized, and the number of neutrophils that transmigrated was increased 10-fold. Priming of the neutrophils with TNFalpha before the addition of ANCA further increased the stability of neutrophil binding, but did not significantly increase transmigration.
CONCLUSION: Rather than frustrating the transmigration process, ANCAs promoted the migration of neutrophils through the endothelium. That the effect was evident at a relatively low level of endothelial activation suggests that ANCAs may potentiate the early vasculitic lesion and promote tissue damage and recruitment of other proinflammatory cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11762946     DOI: 10.1002/1529-0131(200112)44:12<2851::aid-art473>3.0.co;2-2

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  20 in total

Review 1.  Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis.

Authors:  Maria C Cid; Marta Segarra; Ana García-Martínez; Jose Hernández-Rodríguez
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

2.  Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.

Authors:  Hong Xiao; Adrian Schreiber; Peter Heeringa; Ronald J Falk; J Charles Jennette
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo.

Authors:  Sarah L Nolan; Neena Kalia; Gerard B Nash; Dia Kamel; Peter Heeringa; Caroline O S Savage
Journal:  J Am Soc Nephrol       Date:  2008-02-27       Impact factor: 10.121

Review 4.  ANCA-negative pauci-immune crescentic glomerulonephritis.

Authors:  Min Chen; Cees G M Kallenberg; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2009-04-28       Impact factor: 28.314

5.  The cleavage of neutrophil leukosialin (CD43) by cathepsin G releases its extracellular domain and triggers its intramembrane proteolysis by presenilin/gamma-secretase.

Authors:  Agnès Mambole; Dominique Baruch; Patrick Nusbaum; Sylvain Bigot; Misa Suzuki; Philippe Lesavre; Minoru Fukuda; Lise Halbwachs-Mecarelli
Journal:  J Biol Chem       Date:  2008-06-27       Impact factor: 5.157

6.  Immunoglobulin subclass determines ability of immunoglobulin (Ig)G to capture and activate neutrophils presented as normal human IgG or disease-associated anti-neutrophil cytoplasm antibody (ANCA)-IgG.

Authors:  T Pankhurst; G Nash; J Williams; R Colman; A Hussain; C Savage
Journal:  Clin Exp Immunol       Date:  2011-03-10       Impact factor: 4.330

Review 7.  Endothelium-neutrophil interactions in ANCA-associated diseases.

Authors:  Lise Halbwachs; Philippe Lesavre
Journal:  J Am Soc Nephrol       Date:  2012-09       Impact factor: 10.121

Review 8.  Mechanisms of Autoantibody-Induced Pathology.

Authors:  Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

9.  Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles.

Authors:  Ying Hong; Despina Eleftheriou; Abdullah A K Hussain; Fiona E Price-Kuehne; Caroline O Savage; David Jayne; Mark A Little; Alan D Salama; Nigel J Klein; Paul A Brogan
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

Review 10.  Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides.

Authors:  Ora Shovman; Boris Gilburd; Gisele Zandman-Goddard; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.